Physician profile
Brian D Montgomery
NPI 1356788301
$5,677.10
in general payments reported to CMS, 2019-2025
45 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $799 · 2020: $237 · 2021: $1,010 · 2022: $828 · 2023: $1,066 · 2024: $437 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,519 · Education: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,518.77 |
| Education | $283.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $820.82 | 2019-2025 | Myrbetriq, Xtandi |
| Abbvie INC. | $531.61 | 2019-2025 | |
| Janssen Biotech, INC. | $420.67 | 2019-2025 | Erleada |
| Cipla USA INC. | $413.94 | 2021 | |
| Endo Pharmaceuticals INC. | $306.19 | 2019-2023 | Aveed, Xiaflex |
| Boston Scientific Corporation | $207.16 | 2019-2025 | Lumenis Pulse 120h, Spaceoar Vue System - 10ml, Spaceoar System |
| Abiomed | $206.54 | 2023 | Impella |
| Amgen INC. | $201.48 | 2019-2023 | Xgeva |
| Procept Biorobotics Corporation | $197.64 | 2022-2025 | Aquabeam Robotic System |
| Coloplast Corp | $197.12 | 2021-2025 | Speedicath |
| Sumitomo Pharma America, INC. | $191.74 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $168.26 | 2019-2022 | |
| Myovant Sciences INC. | $156.81 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.61 | 2019-2024 | |
| Calyxo, INC. | $139.80 | 2025 | Cvac Aspiration System |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $124.73 | 2022-2025 | |
| 180 Medical, INC. | $109.13 | 2023-2025 | Gentlecath |
| Ferring Pharmaceuticals INC. | $98.35 | 2019-2025 | Adstiladrin |
| Valencia Technologies Corporation | $87.18 | 2025 | Ecoin Device Kit |
| Laborie Medical Technologies Corp. | $84.56 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $79.76 | 2019-2025 | Itind System |
| Endo USA, INC. | $72.45 | 2025 | Aveed, Xiaflex |
| Astrazeneca Pharmaceuticals Lp | $59.10 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $55.85 | 2019-2022 | |
| Ethicon US, LLC | $51.26 | 2025 | Harmonic, Enseal, Echelon; Endopath |
| Urogen Pharma, INC. | $49.41 | 2021-2022 | |
| Therapeuticsmd, INC. | $48.01 | 2019-2020 | |
| Allergan, INC. | $42.34 | 2021 | |
| Urovant Sciences INC | $41.55 | 2022 | |
| Merck Sharp & Dohme LLC | $33.75 | 2023-2024 | Keytruda, Welireg, Lynparza |
| Bioprotect Medical, INC. | $32.92 | 2024 | Bioprotect Balloon Implant System |
| Innovation Technologies INC | $32.43 | 2025 | Irrisept |
| Blue Earth Diagnostics | $28.55 | 2022 | |
| Verity Pharmaceuticals INC. | $27.58 | 2024 | Trelstar |
| Tolmar, INC. | $26.44 | 2023 | |
| Angiodynamics, INC. | $24.28 | 2022 | |
| Profound Medical Corp. | $23.87 | 2025 | Tulsa-Pro |
| C. R. Bard, INC. & Subsidiaries | $22.87 | 2022 | |
| Convatec INC. | $22.67 | 2023 | |
| Axonics, INC. | $20.09 | 2022 | |
| Myriad Genetic Laboratories, INC. | $19.50 | 2023 | Prolaris |
| Karl Storz Endoscopy-America | $13.45 | 2020 | |
| Dentsply Ih Ab | $13.23 | 2023 | Lofric |
| Kowa Pharmaceuticals America, INC. | $13.04 | 2023 | Seglentis |
| Dornier Medtech America, INC | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Montgomery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.